Today we are speaking with Rose Weinstein, Vice President of Clinical Affairs at Moximed. Rose has her hands full preparing for post-market clinical studies after Moximed brought their implantable shock absorber, the MISHA™ Knee System, to market in April 2023. Prior to joining Moximed in 2018, Rose spent over 5 years as a clinical research associate before joining NeoTract as a manager of clinical affairs. Listen as Rose explains why data-driven decisions are the future of medical breakthroughs and how they shape the path to excellence in clinical research. From the power of patient stories to the significance of post-market studies, this episode offers a comprehensive view of the clinical research journey.